series-b
Stage
1
Investors
About
Ten63 Therapeutics develops therapeutics by combining generative chemistry with quantum-accurate simulations to design drugs targeting previously undruggable diseases, focusing on oncology and other serious diseases.
Explore Ten63's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.